Skip to Main Content

Author Details

Amy G Robertson
Present address: Dxige Research Inc.
2003
98
54
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36911097Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling.Cancer Res Commun2023
37095257The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Oncogene2023
36911097Tumor-derived GCSF Alters Tumor and Systemic Immune System Cell Subset Composition and Signaling.Cancer Res Commun2023
37084275spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape.Bioinformatics2023
37105962Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.Nat Commun2023
37084275spongEffects: ceRNA modules offer patient-specific insights into the miRNA regulatory landscape.Bioinformatics2023
37105962Expression-based subtypes define pathologic response to neoadjuvant immune-checkpoint inhibitors in muscle-invasive bladder cancer.Nat Commun2023
37095257The DACH1 gene is frequently deleted in prostate cancer, restrains prostatic intraepithelial neoplasia, decreases DNA damage repair, and predicts therapy responses.Oncogene2023
36192513A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.Sci Rep2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
35368077cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.Brief Bioinform2022
36197969Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.Sci Adv2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36192513A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma.Sci Rep2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
35368077cSurvival: a web resource for biomarker interactions in cancer outcomes and in cell lines.Brief Bioinform2022
35810190Multi-modal molecular programs regulate melanoma cell state.Nat Commun2022
36564410Author Correction: FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
36197969Immune activation is essential for the antitumor activity of EZH2 inhibition in urothelial carcinoma.Sci Adv2022
36323682FOXA1 repression drives lineage plasticity and immune heterogeneity in bladder cancers with squamous differentiation.Nat Commun2022
33436690Synthesis and tumour cell uptake studies of gadolinium(III)-phosphonium complexes.Sci Rep2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33982016Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer.STAR Protoc2021
33599224Gadolinium theranostics for the diagnosis and treatment of cancer.Chem Soc Rev2021
33436690Synthesis and tumour cell uptake studies of gadolinium(III)-phosphonium complexes.Sci Rep2021
35028613Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Cell Rep Med2021
33626341Whole-genome characterization of lung adenocarcinomas lacking alterations in the RTK/RAS/RAF pathway.Cell Rep2021
33599224Gadolinium theranostics for the diagnosis and treatment of cancer.Chem Soc Rev2021
35028613Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.Cell Rep Med2021
33982016Integrative modeling identifies genetic ancestry-associated molecular correlates in human cancer.STAR Protoc2021
32312542Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant Immunotherapy.Eur Urol2020
32312542Immune Signatures Dominate Molecular Subtyping to Predict Response to Neoadjuvant Immunotherapy.Eur Urol2020
32037144Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.Eur Urol2020
32994066Reply to Fredrik Liedberg, Pontus Eriksson, and Gottfrid Sjödahl's Letter to the Editor re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol;2020:533-7.Eur Urol2020
32037144Reply To Kenneth B. Yatai, Mark J. Dunning, Dennis Wang. Consensus Genomic Subtypes of Muscle-invasive Bladder Cancer: A Step in the Right Direction but Still a Long Way To Go. Eur Urol 2020;77:434-5.Eur Urol2020
32994066Reply to Fredrik Liedberg, Pontus Eriksson, and Gottfrid Sjödahl's Letter to the Editor re: A. Gordon Robertson, Clarice S. Groeneveld, Brian Jordan, et al. Identification of Differential Tumor Subtypes of T1 Bladder Cancer. Eur Urol;2020:533-7.Eur Urol2020
30923832RTNsurvival: an R/Bioconductor package for regulatory network survival analysis.Bioinformatics2019
30923832RTNsurvival: an R/Bioconductor package for regulatory network survival analysis.Bioinformatics2019
31250887RTNduals: an R/Bioconductor package for analysis of co-regulation and inference of dual regulons.Bioinformatics2019
31250887RTNduals: an R/Bioconductor package for analysis of co-regulation and inference of dual regulons.Bioinformatics2019
29316429Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma.Cancer Cell2018
30361341The chromatin accessibility landscape of primary human cancers.Science2018
30268436A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF-β Superfamily.Cell Syst2018
29925010The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
30096301Comprehensive Molecular Characterization of Muscle-Invasive Bladder Cancer.Cell2018
30413703Transcriptome-wide identification of transient RNA G-quadruplexes in human cells.Nat Commun2018
29625048Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.Cell2018
29622464A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.Cancer Cell2018
29617669The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.Cell Rep2018
29617660Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.Cell Rep2018
  • 1 - 50 of 196

Recommended Authors

University of Texas Southwestern Medical Center
Career Start Year 2014
Number of shared co-authors 8
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 15
Johns Hopkins University School of Medicine
Career Start Year 2010
Number of shared co-authors 8
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 1
Broad Institute of Harvard and MIT
Career Start Year 2010
Number of shared co-authors 5
National Institute of Data Science in Health and Medicine, Xiamen University
Career Start Year 2008
Number of shared co-authors 8
St. Jude Children's Research Hospital
Career Start Year 2006
Number of shared co-authors 16
Dana-Farber Cancer Institute
Career Start Year 2006
Number of shared co-authors 13
The University of Texas MD Anderson Cancer Center
Career Start Year 2006
Number of shared co-authors 6
Prostate Cancer Research Center, Tampere University and Tays Cancer Center
Career Start Year 2006
Number of shared co-authors 20
University of Colorado Anschutz Medical Campus
Career Start Year 2006
Number of shared co-authors 10
Baylor College of Medicine
Career Start Year 2005
Number of shared co-authors 12
Genentech Inc.
Career Start Year 2004
Number of shared co-authors 16
Roswell Park Comprehensive Cancer Center
Career Start Year 2003
Number of shared co-authors 2
University of California
Career Start Year 2003
Number of shared co-authors 3
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 16
Fox Chase Cancer Center
Career Start Year 2002
Number of shared co-authors 1
Virginia Commonwealth University
Career Start Year 2001
Number of shared co-authors 3
The University of Texas Health Science Center at San Antonio
Career Start Year 2001
Number of shared co-authors 9
Center for Immunotherapy and Precision-Immuno-Oncology, Cleveland Clinic
Career Start Year 2001
Number of shared co-authors 19
Institute for Computational Biomedicine
Career Start Year 2000
Number of shared co-authors 27
Mayo Clinic
Career Start Year 2000
Number of shared co-authors 15
The Scripps Research Institute
Career Start Year 1999
Number of shared co-authors 3
Stanford Center for Biomedical Informatics Research, Stanford University
Career Start Year 1999
Number of shared co-authors 42
The Ohio State University
Career Start Year 1997
Number of shared co-authors 2
German Cancer Research Center (DKFZ)
Career Start Year 1997
Number of shared co-authors 23
Columbia University
Career Start Year 1993
Number of shared co-authors 59
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 13
University of California San Diego
Career Start Year 1988
Number of shared co-authors 32
University of California los angeles
Career Start Year 1970
Number of shared co-authors 78

Collaborators

University of British Columbia
Co-authored papers 38
University of British Columbia
Co-authored papers 26
Dana-Farber Cancer Institute
Co-authored papers 23
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Co-authored papers 22
The University of Texas MD Anderson Cancer Center
Co-authored papers 22
Van Andel Institute
Co-authored papers 17
Co-authored papers 16
University of British Columbia
Co-authored papers 14
Co-authored papers 14
Knight Cancer Institute, Oregon Health and Sciences University
Co-authored papers 13
The University of Texas MD Anderson Cancer Center
Co-authored papers 13
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 13
Federal University of Parana
Co-authored papers 13
Van Andel Institute
Co-authored papers 12
University of California San Francisco
Co-authored papers 11
Buck Institute for Research on Aging
Co-authored papers 10
Co-authored papers 9
Co-authored papers 9
Co-authored papers 9
BC Cancer Research Institute
Co-authored papers 9
Co-authored papers 9
Canada British Columbia Cancer Research Centre, University of British Columbia
Co-authored papers 8
Co-authored papers 8
Baylor College of Medicine
Co-authored papers 8
Co-authored papers 8
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
National Cancer Institute
Co-authored papers 8
Broad Institute
Co-authored papers 8
University of California at Santa Cruz
Co-authored papers 7
Brain Tumour Foundation of Canada
Co-authored papers 7